Background
Leszek Krzysztof Borysiewicz) was born in Cardiff, Wales, to January and Zofia (née Wołoszyn) Borysiewicz, ethnic Polish World World War II-era refugees (from what is present-day Belarus) who came to Great Britain with the Anders" Army.
Leszek Krzysztof Borysiewicz) was born in Cardiff, Wales, to January and Zofia (née Wołoszyn) Borysiewicz, ethnic Polish World World War II-era refugees (from what is present-day Belarus) who came to Great Britain with the Anders" Army.
Borysiewicz studied medicine at Welsh National School of Medicine and received a Doctor of Philosophy from the Royal Postgraduate Medical School in 1986 for his thesis, entitled Cell mediated immunity to human cytomegalovirus infection (cytotoxic T cell and natural killer cell mediated lysis of human cytomegalovirus infected cells).
He is currently the 345th Vice-Chancellor of the University of Cambridge, his term of office (a maximum of seven years) having started on 1 October 2010. Borysiewicz was formerly chief executive of the United Kingdom"s Medical Research Council. Borysiewicz pursued a career in academic medicine at the University of Cambridge, where he was a fellow of Wolfson College, and then as a consultant at Hammersmith Hospital.
He headed the Department of Medicine at the University of Wales before joining Imperial College London, where he was promoted to Deputy Rector responsible "for the overall academic and scientific direction of the College," In September 2007, it was reported he would succeed Colin Blakemore as the 9th head of the Medical Research Council, a national organisation that supports medical science with an annual budget of around £500 million.
Borysiewicz"s research focuses on viral immunology, infectious disease, and viral-induced cancer. He has co-authored and co-edited a number of books on these subjects, including Vaccinations.
Royal Society]
He is also a Governor of the Wellcome Trust, a council member of Cancer Research United Kingdom, a founding fellow of the Academy of Medical Sciences and co-chair of the Medical Research Council"s advisory group on stem cell research.